Institute of High Performance Computing, Sembcorp Marine Ltd, University of Glasgow and University of Glasgow Singapore Signs a Memorandum of Understanding to Collaborate and Develop New Hull Designs
Jan 21 15
Institute of High Performance Computing, Sembcorp Marine Ltd, University of Glasgow and University of Glasgow Singapore have signed a memorandum of understanding (MoU) to collaborate and develop new hull designs for large ocean-going vessels and make them more environmentally friendly. Under the three-year MoU, IHPC, Sembcorp Marine Ltd, University of Glasgow and UGS will use computational modeling and visualisation technologies to design vessels with improved hydrodynamics for better fuel efficiency. In addition, they will collaborate and innovate on features to reduce harmful exhaust emissions and discharges by enhancing the vessel's scrubber and ballast treatment systems. The partnership will form an eco-system that creates value from unique technologies and research talent. The collaboration will employ multi-physics computation to build modeling and simulation capabilities. It will combine the scientific expertise from IHPC, University of Glasgow and UGS, with Sembcorp Marine's knowledge and wealth of experience in industrial maritime applications. Under this research collaboration, Sembcorp Marine and IHPC will analyse and improve gas abatement technology, using an enhanced scrubber design to address the emission of harmful gases like sulphur oxides (SOx), nitrous oxides (NOx), particulate matter and greenhouse gases, in particular CO2, from the ship's heavy fossil fuel burning combustion engines. Such designs and technology are also needed to meet the International Maritime Organization's new 2015 standards on ship-related air pollutants and marine environmental issues. Beyond the current areas of focus, the three organizations hope to expand the scope of the collaboration to create a more comprehensive package of solutions for more efficient ocean-going vessels. The partners are also looking at the possibility of a joint laboratory to advance R&D in this area.
GLASGOW University's Stratified Medicine Scotland Innovation Centre Names David U Prichard as Founding Chairman
May 23 13
GLASGOW University’s innovation centre has appointed its founding chairman. The global life science entrepreneur, Dr. David U Prichard, will take on the role at the Stratified Medicine Scotland Innovation Centre. Dr. U Prichard is currently president of Druid Consulting LLC, chief scientific officer at BioMotiv LLC.
miRagen Therapeutics, Inc. Exclusively Licenses Intellectual Property from the University of Glasgow for microRNA-145 Targeting in the Treatment of Pulmonary Arterial Hypertension
Mar 5 13
miRagen Therapeutics Inc. and the University of Glasgow announced that they have signed an exclusive license agreement for intellectual property they developed as part of an ongoing collaboration for microRNA-145 in pulmonary arterial hypertension. This licensing agreement provides miRagen with exclusive rights to an important discovery made in collaboration with the University of Glasgow and the University of Cambridge, enabling miRagen to advance miR-145 inhibition as a potential therapeutic approach for PAH.